Upper Respiratory Tract Infection (URTI) is very common in clinical practice. Most infections are caused by virus and bacteria; the proportion caused by viruses is much greater. Antibiotics rarely benefit in URTI, still they are widely prescribed in the treatment of URTI. Studies indicate antibiotics do not hasten resolution of symptoms in URTI. In a clinical trial, Nirocil Tablets containing single ingredient Tamalaki (Phyllanthus niruri, Syn. Phyllanthus amarus), was proven to have beneficial role in the treatment of Non Bacterial Upper Respiratory Tract Disorders as compared to a placebo. Nirocil Syrup is indicated for recurrent URTI in pediatric population. In addition to Tamalaki (Phyllanthus niruri), Nirocil Syrup contains an important immunomodulatory herb Guduchi (Tinospora cordifolia).
|Each coated tablet contains extract derived from:|
|Tamalaki (Phyllanthus niruri)||1000 mg|
|Each 5 ml contains extract derived from:|
|Tamalaki (Phyllanthus niruri)||400 mg|
|Eranda (Ricinus communis)||200 mg|
|Guduchi (Tinospora cordifolia)||50 mg|
|Yashada Bhasma||0.1 mg|
- Accelerates clinical recovery
- Reduces severity of infection
- Protects the liver
Upper respiratory tract infection.
Other viral infections like Mumps, Measles, Chicken pox & Herpes zoster.
Viral Hepatitis (Hepatitis B)
One tablet thrice daily or as directed by the Physician.
Children: 5 ml thrice daily.
Adults: 10-15 ml thrice daily or as directed by the Physician.
Tablets: Strip of 30 Tablets
Syrup: 110 ml